In vitro/in vivo: Cholesterol-treated CD8+ T cells had upregulation in lipid-metabolism related genes, and especially in the ER-stress-response genes such as XBP1. In vivo: Cholesterol depletion reduced the tumor volume and the number of tumor foci. The gene discussed is XBP1; the disease is neoplasm.